Roche to halt lung-cancer drug trial after disappointing data

by | Jul 4, 2024 | Stock Market

Roche Holding said it plans to halt a mid- and late-stage clinical study for a combination of drugs to treat lung cancer after it failed to meet the trial’s primary efficacy goals.

Article Attribution | Read More at Article Source

[mwai_chat context=”Let’s have a discussion about this article:nnRoche Holding said it plans to halt a mid- and late-stage clinical study for a combination of drugs to treat lung cancer after it failed to meet the trial’s primary efficacy goals.nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]
Share This